Controls & Specialty Plasmas
Diagnostic Kits
Customized Solutions

News & Events

May 09, 2022

CRYOcheck™ Chromogenic Factor IX Assay Authorized for Sale in Canada, EU, UK, and Australasia

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the launch of its new CRYOcheck Chromogenic Factor IX assay in Canada, the European Union, United Kingdom, Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities. The announcement was made at the World...

On The Fritsma Factor

May 18, 2022

Reminder, in 2020, the International Society for Thrombosis and Hemostasis [ISTH } released...